Upgrade to SI Premium - Free Trial

Repligen (RGEN)

167.60 -2.01 (1.19%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/3/26)

Latest Headlines

Repligen (RGEN) PT Raised to $210 at HSBC September 1, 2026 2:16 AM - StreetInsider Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference August 26, 2026 7:30 AM - Globe NewsWire Form S-4 REPLIGEN CORP August 25, 2026 6:04 AM - SEC Filing Form 4 REPLIGEN CORP For: Aug 20 Filed by: Loeillot Olivier August 21, 2026 4:06 PM - SEC Filing Form 144 REPLIGEN CORP Filed by: Loeillot Olivier August 20, 2026 11:54 AM - SEC Filing Repligen (RGEN) call put ratio 5.6 calls to 1 put August 19, 2026 11:23 AM - StreetInsider Repligen (RGEN) call put ratio 1 call to 6.7 puts into share price up before the bell August 19, 2026 9:12 AM - StreetInsider Form SCHEDULE 13G/A REPLIGEN CORP Filed by: PRICE T ROWE ASSOCIATES INC /MD/ August 14, 2026 10:39 AM - SEC Filing Form SCHEDULE 13G REPLIGEN CORP Filed by: VANGUARD CAPITAL MANAGEMENT LLC July 31, 2026 10:46 AM - SEC Filing Repligen (RGEN) PT Raised to $185 at Wells Fargo July 30, 2026 8:35 AM - StreetInsider Form 10-Q REPLIGEN CORP For: Jun 30 July 29, 2026 4:21 PM - SEC Filing Repligen (RGEN) PT Raised to $175 at JPMorgan July 29, 2026 8:55 AM - StreetInsider Canaccord Reiterates Hold Rating on Repligen (RGEN) July 29, 2026 6:47 AM - StreetInsider Repligen (RGEN) PT Raised to $185 at RBC Capital July 29, 2026 6:21 AM - StreetInsider Repligen (RGEN) PT Raised to $160 at Wolfe Research July 29, 2026 5:35 AM - StreetInsider Repligen (RGEN) PT Raised to $160 at Jefferies July 28, 2026 1:21 PM - StreetInsider Form 8-K REPLIGEN CORP For: Jul 28 July 28, 2026 7:14 AM - SEC Filing Repligen (RGEN) Tops Q2 EPS by 9c ; Offers Guidance July 28, 2026 7:11 AM - StreetInsider Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance July 28, 2026 7:00 AM - Globe NewsWire Canaccord Reiterates Hold Rating on Repligen (RGEN) July 23, 2026 7:25 AM - StreetInsider Form 425 REPLIGEN CORP Filed by: REPLIGEN CORP July 22, 2026 9:01 AM - SEC Filing Form 8-K REPLIGEN CORP For: Jul 21 July 22, 2026 8:57 AM - SEC Filing Repligen to acquire BioLife Solutions for ~$1.5B July 22, 2026 6:00 AM - StreetInsider Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media July 22, 2026 6:00 AM - Globe NewsWire Form 4 REPLIGEN CORP For: Jul 16 Filed by: Garland Jason K July 17, 2026 4:41 PM - SEC Filing Form 144 REPLIGEN CORP Filed by: Garland Jason K July 16, 2026 1:45 PM - SEC Filing Repligen to Report Second Quarter 2026 Financial Results July 15, 2026 7:30 AM - Globe NewsWire Benchmark Upgrades Repligen (RGEN) to Buy July 7, 2026 6:26 AM - StreetInsider Form 4 REPLIGEN CORP For: Jun 25 Filed by: Garland Jason K June 26, 2026 4:05 PM - SEC Filing Form 144 REPLIGEN CORP Filed by: Garland Jason K June 25, 2026 1:55 PM - SEC Filing Full Article List